Emergency Pharmacology: New Agents, Revised Protocols, and Antimicrobial Stewardship

This chapter reviews clinically significant developments in emergency pharmacotherapy, including the introduction of novel analgesics, procedural sedation agents, and reversal agents for anticoagulant and neuromuscular blocking drugs. It examines updated evidence for the use of corticosteroids, vasopressors, and blood products in critical illness, and addresses the critical role of the emergency physician in antimicrobial stewardship, covering appropriate empirical antibiotic selection, de-escalation strategies, and the management of multidrug-resistant organisms in the emergency setting.